We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China Bans Import and Sale of BMS’ Cancer Drug Abraxane
China Bans Import and Sale of BMS’ Cancer Drug Abraxane
China’s National Medical Products Administration (NMPA) has banned the importation, sale and use of Bristol-Myers Squibb’s cancer blockbuster Abraxane (nanoparticle albumin-bound paclitaxel) following an inspection in the U.S.